Restore Mind Medicine
100 Day Plan
We expect to create immediate value as our plan is designed to provide a rapid,
comprehensive review of MindMed within 75 days.
Rapid Review
25 Days
• Review UHB data and
working on protocol for
MM-120 Program.
• Conduct a rapid
assessment of MindMed's
cost structure.
Initiate reviews in MM-402
and digital medicine.
Analyze and allocate
resources to support
MM-120 in ADHD.
Streamlining
Operations
50 Days
●
Implement the results of
the cost structure review
to bring MindMed's
overhead in line.
Implement MM-120 Phase
III plan.
• Continued close
collaboration with UHB.
75 Days
●
Implementation
of Pillars
●
Prepare for FDA meeting
and meeting with CROS.
Strengthening MindMed's
outside consultancy
relationships.
Communicating with
stakeholders about how
our plan has progressed
during the first 75 days.
Drive Shareholder
Value
100 Days & Beyond
• Execute on Phase III trial.
Evaluating MM-110 and
other drugs for future
R&D.
●
●
Continuing to provide
strong corporate
accountability and
transparency.
20View entire presentation